Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content ...

Former Sanofi subsidiary Zentiva has signed off on up to 220 million euros for the rights to commercialize and manufacture an ...

Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...

A Google Translate screenshot correctly shows that the name of the pharmaceutical company AstraZeneca, when written as “A ...

Ken Hall takes a closer look at GSK after the FTSE 100 pharmaceutical giant's positive first quarter earnings update.

AstraZeneca and British American Tobacco today provided fresh support for the FTSE 100 index at the end of a positive week ...

The ruling, seen as a major victory for transparency campaigners, piles pressure on Ursula von der Leyen over the opaque ...

Astrazeneca and GSK have extensive activity in the US market. Shares in London-listed drugmakers GSK and Astrazeneca tumbled ...

US President Trump wants to make medicines cheaper in the US, which could mean huge losses for drugmakers, including those in ...

Shares in London-based pharmaceutical companies GSK and Astrazeneca experienced a significant drop on Monday morning ...

AstraZeneca recently released positive results from its POTOMAC Phase III trial involving IMFINZI, reflecting significant advancements in treatment for high-risk non-muscle-invasive bladder cancer.

Investors in AstraZeneca plc (Symbol: AZN) saw new options become available today, for the June 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AZN ...